European Society of Urogenital Radiology. ESUR guidelines on Contrast Agents. Version 10. Available at: http://www.esur.org/esur-guidelines. Accessed: 6th February 2019
G. Chalikias, I. Drosos, and D. N. Tziakas, “Contrast-Induced Acute Kidney Injury: An Update,” Cardiovasc. Drugs Ther., vol. 30, no. 2, pp. 215–228, 2016.
E. Chong, K. Poh, S. Liang, and H. Tan, “Risk factors and clinical outcomes for contrast-induced nephropathy after percutaneous coronary intervention in patients with normal serum creatinine,” Ann Acad Med Singapore, vol. 39, pp. 374–380, 2010.
R. Nicola, K. W. Shaqdan, K. Aran, M. Mansouri, A. Singh, and H. H. Abujudeh, “Contrast-Induced Nephropathy: Identifying the Risks, Choosing the Right Agent, and Reviewing Effective Prevention and Management Methods,” Curr. Probl. Diagn. Radiol., vol. 44, no. 6, pp. 501–504, 2015.
P. Kolh et al., “2014 ESC/EACTS Guidelines on myocardial revascularization,” Eur. J. Cardio-thoracic Surg., vol. 46, no. 4, pp. 517–592, 2014.
D. J. McKillop and P. Auld, “National turnaround time survey: professional consensus standards for optimal performance and thresholds considered to compromise efficient and effective clinical management,” Ann. Clin. Biochem., vol. 54, no. 1, pp. 158–164, 2017.
C. S. Kosack, W. De Kieviet, K. Bayrak, A. Milovic, and A. L. Page, “Evaluation of the Nova StatSensor® XpressTM™ creatinine point-of-care handheld analyzer,” PLoS One, vol. 10, no. 4, pp. 1–11, 2015.
C. Srihong, K. Pangsapa, K. Chuaboonmee, Y. Kotipan, and N. Charuruks, “Evaluation of the analytical performance of the nova statsensor creatinine meter for blood testing,” J. Med. Assoc. Thail., vol. 95, no. 9, pp. 1225–1231, 2012.
A. J. Carden et al., “Prospective observational study of point-of-care creatinine in trauma,” Trauma Surg. Acute Care Open, vol. 1, no. 1, p. e000014, 2016.
C. L. Van Lint et al., “Application of a point of care creatinine device for trend monitoring in kidney transplant patients: Fit for purpose?,” Clin. Chem. Lab. Med., vol. 53, no. 10, pp. 1547–1556, 2015.
P. Delanaye et al., “Iohexol plasma clearance for measuring glomerular filtration rate in clinical practice and research: A review. Part 1: How to measure glomerular filtration rate with iohexol?,” Clin. Kidney J., vol. 9, no. 5, pp. 682–699, 2016.
A. S. Levey et al., “A New Equatio,” vol. 150, no. 9, pp. 604–612, 2009.
E. Cavalier et al., “Performance of iohexol determination in serum and urine by HPLC: Validation, risk and uncertainty assessment,” Clin. Chim. Acta, vol. 396, no. 1–2, pp. 80–85, 2008.
K. L. Schnabl, S. Bagherpoor, P. Diker, C. Cursio, J. DuBois, and P. M. Yip, “Evaluation of the analytical performance of the Nova StatSensor creatinine meter and reagent strip technology for whole blood testing,” Clin. Biochem., vol. 43, no. 12, pp. 1026–1029, 2010.
P. Calzavacca, A. Tee, E. Licari, A. G. Schneider, and R. Bellomo, “Point-of-care measurement of serum creatinine in the intensive care unit,” Ren. Fail., vol. 34, no. 1, pp. 13–18, 2012.
A. Udy, S. O'’Donoghue, V. D'’Intini, H. Healy, and J. Lipman, “Point of care measurement of plasma creatinine in critically ill patients with acute kidney injury,” Anaesthesia, vol. 64, no. 4, pp. 403–407, 2009.
B. Snaith et al., “Point of care creatinine testing in diagnostic imaging: A feasibility study within the outpatient computed tomography setting,” Eur. J. Radiol., vol. 112, no. January, pp. 82–87, 2019.
J. H. Nichols et al., “Clinical outcomes of point-of-care testing in the interventional radiology and invasive cardiology setting,” Clin. Chem., vol. 46, no. 4, pp. 543–550, 2000.
G. Marenzi, E. Assanelli, and I. Marana, “N-acetylcysteine and contrast-induced nephropathy in primary angioplasty,” N Engl J Med, vol. 354, pp. 2773–2782, 2006.
G. V. Karamasis et al., “Impact of point-of-care pre-procedure creatinine and eGFR testing in patients with ST segment elevation myocardial infarction undergoing primary PCI: The pilot STATCREAT study,” Int. J. Cardiol., vol. 240, pp. 8–13, 2017.
Westgard QC Quality Requirements: Desirable Specifications for Total Error, Imprecision, and Bias, derived from intra- and inter-individual biologic variation. Available at: https://www.westgard.com./biodatabase1.htm Accessed: 15th April 2019
B. Snaith, M. a. Harris, B. Shinkins, M. Jordaan, M. Messenger, and A. Lewington, “Point-of-care creatinine testing for kidney function measurement prior to contrast-enhanced diagnostic imaging: Evaluation of the performance of three systems for clinical utility,” Clin. Chem. Lab. Med., vol. 56, no. 8, pp. 1269–1276, 2018.
L. Bogaert, T. Schiemsky, P. Van Hover, P. De Schrijver, and L. Van Hoovels, “Letter to the Editor Analytical and diagnostic performance evaluation of five creatinine POCT devices in the identification of patients at risk for post-contrast acute kidney injury (PCAKI),” pp. 2–5, 2019.
B. R. Griffin et al., “Unadjusted point of care creatinine results overestimate acute kidney injury incidence during field testing in Guatemala,” PLoS One, vol. 13, no. 9, pp. 1–12, 2018.
P. Delanaye et al., “Iohexol plasma clearance for measuring glomerular filtration rate in clinical practice and research: a review. Part 2: Why to measure glomerular filtration rate with iohexol?,” Clin. Kidney J., vol. 9, no. 5, pp. 700–704, 2016.